Pre‐diagnostic levels of sVEGFR2, sTNFR2, sIL‐2Rα and sIL‐6R are associated with glioma risk: A nested case–control study of repeated samples

The association between change of soluble tumor necrosis factor receptor R1 (sTNF-R1) measurements and cardiovascular and all-cause mortality—Results from the population-based (Cardiovascular Disease, Living and Ageing in Halle) CARLA study 2002–2016

(2020) Lamiaa Hassan et al.   PLoS One

Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target

(2019) Juliane Medler et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Genetic and molecular epidemiology of adult diffuse glioma

(2019) Annette M. Molinaro et al.   Nature Reviews Neurology

Pre‐diagnostic serum sCD27 and sCD30 in serial samples and risks of non‐Hodgkin lymphoma subtypes

(2019) Mark P. Purdue et al.   INTERNATIONAL JOURNAL OF CANCER

Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model

(2018) Bogdan Mitran et al.   Theranostics

Serially measured pre-diagnostic levels of serum cytokines and risk of brain cancer in active component military personnel

(2018) Alina V. Brenner et al.   BRITISH JOURNAL OF CANCER

VEGF as a modulator of the innate immune response in glioblastoma

(2017) Kati Turkowski et al.   GLIA

Immune microenvironment of gliomas

(2017) Anna Gieryng et al.   LABORATORY INVESTIGATION

Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors

(2017) Beatrice S Melin et al.   NATURE GENETICS

A nested case-control study of 277 prediagnostic serum cytokines and glioma

(2017) Judith Schwartzbaum et al.   PLoS One

Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study

(2016) E. S. Amirian et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma

(2016) Manmeet S. Ahluwalia et al.   JOURNAL OF NEURO-ONCOLOGY

Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential

(2015) Koen van de Ven et al.   Immunotherapy

Fitting Linear Mixed-Effects Models Usinglme4

(2015) Douglas Bates et al.   Journal of Statistical Software

Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma

(2015) Judith Schwartzbaum et al.   PLoS One

The role of regulatory T-cells in glioma immunology

(2014) Yinn Cher Ooi et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation

(2013) T. T. Batchelor et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting Tregs in Malignant Brain Cancer: Overcoming IDO

(2013) Derek A. Wainwright et al.   Frontiers in Immunology

Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours

(2012) Aleksandra Mielczarek-Palacz et al.   Archives of Medical Science

Cytokine networks in glioma

(2011) Kenichiro Iwami et al.   NEUROSURGICAL REVIEW

Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+regulatory T cells in human peripheral blood

(2010) Xin Chen et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Tumor necrosis factor (TNF)-α, soluble TNF receptors and endometrial cancer risk: The EPIC study

(2010) Laure Dossus et al.   INTERNATIONAL JOURNAL OF CANCER

Genetic variations in VEGF and VEGFR2 and glioblastoma outcome

(2010) S. Sjöström et al.   JOURNAL OF NEURO-ONCOLOGY

Atopic Disease and Risk of Non-Hodgkin Lymphoma: An InterLymph Pooled Analysis

(2009) C. M. Vajdic et al.   CANCER RESEARCH

Serum soluble interleukin 2 receptor α in human cancer of adults and children: a review

(2008) E. Bien et al.   BIOMARKERS